Close Menu

A short story by the Weizmann Institute of Science's Peter Tsvetkov and Tel-Aviv University's Sharon Dekel posted at LabLit this week details a personified p53's visit with a "gene therapist." The transcription factor, it seems, is at odds with his roles in cancer and apoptosis. "When I was first discovered they accused me of being oncogenic, accused me of supporting cancer. It took them many years to understand that I am the good guy, that I'm a tumor suppressor.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.